<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To assess the 5-year incidence of clinically presenting <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> following a negative CT colonography (CTC) screening examination, as few patient outcome data regarding a negative CTC screening result exist </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Negative CTC screening patients (n = 1,050) in the University of Wisconsin Health system over a 14-month period were included </plain></SENT>
<SENT sid="2" pm="."><plain>An electronic medical record (EMR) review was undertaken, encompassing provider, colonoscopy, imaging and histopathology reports </plain></SENT>
<SENT sid="3" pm="."><plain>Incident <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> and other important GI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> were recorded </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of the 1,050 cohort (mean [±SD] age 56.9 ± 7.4 years), 39 (3.7%) patients were excluded owing to lack of follow-up within our system beyond the initial screening CTC </plain></SENT>
<SENT sid="5" pm="."><plain>The remaining 1,011 patients were followed for an average of 4.73 ± 1.15 years </plain></SENT>
<SENT sid="6" pm="."><plain>One incident colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> represented a crude <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence of 0.2 cancers per 1,000 patient years </plain></SENT>
<SENT sid="7" pm="."><plain>EMR revealed 14 additional patients with clinically important GI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> including: advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> (n = 11), appendiceal goblet cell <z:hpo ids='HP_0100570'>carcinoid</z:hpo> (n = 1), appendiceal mucinous <z:mpath ids='MPATH_270'>adenoma</z:mpath> (n = 1) and metastatic ileocolonic <z:hpo ids='HP_0100570'>carcinoid</z:hpo> (n = 1) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> positive patients including the incident <z:mp ids='MP_0002038'>carcinoma</z:mp> are alive at the time of review </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Clinically presenting colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is rare in the 5 years following negative screening CTC, suggesting that current strategies, including non-reporting of diminutive lesions, are appropriate </plain></SENT>
<SENT sid="10" pm="."><plain>KEY POINTS: • CT colonography (CTC) screening is increasingly used to identify potential <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>. • Clinically presenting <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are rare for 5 years following negative CTC screening. • The practice of setting a 6 mm <z:mpath ids='MPATH_491'>polyp</z:mpath> size threshold seems safe. • An interval of 5 years for routine CTC screening is appropriate </plain></SENT>
</text></document>